Preoperative prediction of GPC3 positive hepatocellular carcinoma and postoperative recurrence with the LI-RADS features on gadoxetate disodium-enhanced MRI
Preoperative prediction of GPC3 positive hepatocellular carcinoma and postoperative recurrence with the LI-RADS features on gadoxetate disodium-enhanced MRI
Objective To investigate the predictive ability of Glypican-3(GPC3)positive hepatocellular carcinoma based on the hepatobiliary specific contrast agent gadoxetate disodium enhancement of the liver imaging reporting and data system version 2018(LI-RADS v2018)imaging features,and to assess the relevant clinical imaging features for postoperative recurrence in GPC3 positive HCC patients.Methods This study was a cohort study.A total of 122 hepatocellular carcinoma patients who underwent gadoxetate disodium enhanced MR1 examination with hepatic tumor resection in Henan Provincial People's Hospital from January 2017 to December 2021 were retrospectively collected,including 96 GPC3 positive and 26 GPC3 negative patients.The imaging features defined by LI-RADS v2018 of HCC lesions were analyzed.Patients were followed up for 40 months to determine recurrence free survival(RFS).The logistic regression was used to analyze the risk factors of GPC3 positivity.An imaging model,and a clinical-imaging model which combined the patient's alpha-fetoprotein levels were constructed.The efficacy of the model for predicting GPC3 positivity was assessed using receiver operating characteristic curves.Kaplan-Meier method was used to draw the survival curve,and the log-rank test was used to compare the RFS between GPC3 positive and negative patients.Risk factors affecting the recurrence of GPC3 positive HCC were assessed by Cox regression.Results The results of logistic multivariate regression analysis confirmed that rim enhancement(OR=5.685,95％CI 1.229-26.287,P=0.026)and irregular tumor margin at hepatobiliary phase(OR=4.431,95％CI 1.684-11.663,P=0.003)were independent risk factors for GPC3 positive HCC.The area under the curve for predicting GPC3 positivity was 0.745(95％CI 0.636-0.854)for the imaging model and 0.776(95％CI 0.677-0.876)for the clinical-imaging model.The mean RFS in the GPC3 positive group was 22 months,and it was 32 months in the negative group.There was a statistically significant difference in RFS between the two groups(x2=5.15,P=0.023).The multivariate Cox regression analysis showed that the arterial rim enhancement(HR=5.460,95％CI 1.966-15.162,P=0.001),microvascular invasion(HR=2.402,95％CI 1.210-4.769,P=0.012),portal vein tumor thrombus(HR=3.226,95％CI1.114-9.344,P=0.031)were independent risk factors for recurrence after hepatic tumor resection for GPC3-positive HCC.Conclusions A model based on the LI-RADS v2018 imaging features of hepatobiliary specific contrast agent gadoxetate disodium enhancement can effectively predict GPC3 positive HCC.The arterial rim enhancement,microvascular invasion and portal vein tumor thrombus are independent risk factors for postoperative recurrence of GPC3 positive HCC.
关键词
癌,肝细胞/磁共振成像/磷脂酰肌醇蛋白聚糖类/肝脏影像报告与数据系统
Key words
Carcinoma,hepatocellular/Magnetic resonance imaging/Glypicans/Liver imaging reporting and data system
维普
万方数据